• When Apoptosis Results Change Meaning

  2026-11-11

  Annexin V fluorescence is a context-dependent readout of accessible cell-surface phosphatidylserine, not a standalone explanation of cell death. In postinfarction research, its meaning depends on the cell population, comparator, disease phase, and how the signal fits with metabolic, inflammatory, histological, and functional evidence.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-11

  A preclinical study examines whether ENO1 links inflammatory macrophage metabolism to post-infarction tissue injury and whether an acid-responsive nanocarrier can test that mechanism through targeted siRNA delivery. The reported findings connect ENO1 silencing with altered glycolysis, lactate–KLF4 signaling, reduced inflammatory features, and improved structural outcomes in a murine infarction model, while leaving important translational and mechanistic questions open.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-10

  A preclinical study links ENO1-dependent glycolytic remodeling in infarct-associated macrophages with inflammatory polarization and evaluates an acid-responsive siRNA nanocarrier as a mechanistic intervention. The findings connect altered lactate signaling, KLF4, macrophage state, and post-infarction tissue outcomes, while remaining bounded by animal-model and short-term safety evidence.

• ENO1, Macrophages, and Cardiac Repair

  2026-11-10

  A preclinical study examines ENO1 as a metabolic regulator of postinfarction macrophage behavior and evaluates an acid-responsive siRNA nanocarrier as a mechanistic research tool. The findings connect glycolytic remodeling, lactate-associated signaling, inflammatory polarization, and cardiac tissue outcomes in murine models.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-09

  A preclinical study examines whether ENO1 links post-infarction macrophage metabolism to inflammatory polarization and whether an acid-responsive nanocarrier can test that mechanism in vivo. The findings support an ENO1–glycolysis–lactate–KLF4 pathway associated with inflammatory macrophage behavior and cardiac remodeling, while remaining bounded by murine models and selected safety assessments.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-09

  A preclinical study links ENO1-associated glycolytic remodeling in infarct-associated macrophages with inflammatory polarization and evaluates an acid-responsive nanocarrier for targeted siRNA delivery. The findings support a macrophage-centered mechanism, while remaining bounded by the experimental models and assessment windows.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-08

  A preclinical study examines ENO1 as a metabolic regulator of inflammatory macrophages after myocardial infarction and evaluates an acid-responsive nanocarrier for testing ENO1 silencing. The reported findings connect altered glycolysis and lactate signaling with macrophage state, cellular targeting, and several cardiac tissue outcomes in experimental models.

• Annexin V Readouts in Postinfarction Repair

  2026-11-07

  Li et al. identify ENO1 as a proposed metabolic regulator of inflammatory macrophages after myocardial infarction and connect ENO1 silencing with lactate reduction, KLF4 recovery, and improved cardiac repair. This editorial explains how an Annexin V-PE apoptosis assay contributes a downstream phosphatidylserine-exposure readout without independently proving irreversible cell death or the upstream ENO1 mechanism.

• ENO1 and Macrophage Metabolism After Myocardial Infarction

  2026-11-06

  A preclinical study links ENO1-driven glycolytic remodeling in infarct-associated macrophages with inflammatory polarization and evaluates an acid-responsive nanocarrier for macrophage-directed siRNA delivery. The findings support a mechanistic connection involving lactate and KLF4, while remaining bounded by murine models, marker-based state definitions, and limited safety assessments.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-06

  A preclinical study links ENO1-driven metabolic remodeling in infarct-associated macrophages to inflammatory polarization and evaluates an acid-responsive siRNA carrier as a mechanistic delivery strategy. The findings support a macrophage–glycolysis–lactate–KLF4 pathway, while remaining bounded by the animal models and assessment windows used.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-05

  A preclinical study examines ENO1 as a metabolic regulator of inflammatory macrophages after myocardial infarction and tests an acid-responsive nanocarrier for selective siRNA delivery. The findings connect ENO1 silencing with reduced glycolytic activity, altered lactate–KLF4 signaling, lower inflammatory polarization, and improved structural and functional cardiac measures in mice, while leaving important questions about mechanism, model translation, and longer-term safety.

• ENO1, Macrophage Metabolism and Cardiac Repair

  2026-11-05

  A preclinical study examines whether ENO1 links macrophage glycolytic remodeling to inflammation after myocardial infarction and uses an acid-responsive nanocarrier to test this relationship in cellular and murine models.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-04

  A preclinical study links ENO1 activity in post-infarction macrophages to glycolytic remodeling, inflammatory polarization, and tissue injury. Its acid-responsive nanocarrier design was used to examine macrophage-focused siRNA delivery and the resulting metabolic, inflammatory, and cardiac readouts in cellular and murine models.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-04

  A preclinical study links ENO1-associated glycolytic remodeling in infarct-associated macrophages to inflammatory polarization and evaluates an acid-responsive siRNA nanocarrier as a mechanistic probe in myocardial infarction models.

• ENO1, Macrophage Metabolism, and Cardiac Repair

  2026-11-03

  A preclinical study examines ENO1 as a metabolic regulator of inflammatory macrophages after myocardial infarction and tests an acid-responsive nanocarrier for localized siRNA delivery. Its findings connect glycolytic remodeling, lactate-associated signaling, macrophage state, and structural cardiac outcomes while leaving important questions about mechanism, model translation, and longer-term safety.

8172 records 1/545 page Next 12345 下5页 Last page